Post

New research · Ophthalmology
Ophthalmic epidemiology · 23h
Cohort studyOphthalmic epidemiology · 2026

Prognostic Biomarkers of Survival in Ocular Melanoma.

Christina N Bobrek, Swara M Sarvepalli, Beth Bailey, Majda Hadziahmetovic
Read paper
OphthalmologyCohort study

Lacrimal gland ocular melanoma had the highest mortality of any primary site studied.

Prognostic Biomarkers of Survival in Ocular Melanoma.

Christina N Bobrek … Majda Hadziahmetovic
Ophthalmic epidemiology · 2026
Purpose

To explore the Surveillance, Epidemiology, and End Results Program (SEER) database in a longitudinal study to determine the factors associated with the risk of death in ocular melanoma.

Methods

With a primary diagnosis of ocular melanoma from the SEER database between 1975 and 2022 were included.

n = 2,917 included patients
Results

every lacrimal gland melanoma patient studied died of the disease

OR 0.98 (95% CI 0.98 to 0.99)
null 1
0.98
0.99
CI excludes the null - significant
More results

Survival analysis with Kaplan-Meier estimate showed lacrimal gland and overlapping lesions of eye and adnexa differed in mean months of survival after diagnosis (54 months and 100.8 months, respectively) compared to conjunctiva and ciliary body (264.5 months and 237.5 months, respectively; p < 0.001).

“
Conclusion

Age and primary site were associated with mortality from ocular melanoma. Overlapping lesions of the eye and adnexa, unspecified ocular site, and choroid were associated with the highest mortality risk from this melanoma.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment